1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.51%
Revenue growth above 1.5x OGI.TO's 3.22%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
7.27%
Positive gross profit growth while OGI.TO is negative. John Neff would see a clear operational edge over the competitor.
-21.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
12.27%
Positive net income growth while OGI.TO is negative. John Neff might see a big relative performance advantage.
16.96%
Positive EPS growth while OGI.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
16.96%
Positive diluted EPS growth while OGI.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
5.73%
Share reduction more than 1.5x OGI.TO's 12.32%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
5.73%
Diluted share reduction more than 1.5x OGI.TO's 12.32%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-91.95%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-81.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
233.46%
Positive 5Y CAGR while OGI.TO is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-47.78%
Negative 3Y CAGR while OGI.TO stands at 63.95%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-1691.31%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-637.63%
Negative 5Y OCF/share CAGR while OGI.TO is at 61.03%. Joel Greenblatt would question the firm’s operational model or cost structure.
-556.05%
Negative 3Y OCF/share CAGR while OGI.TO stands at 49.45%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-5853.83%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-133.36%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
82.42%
3Y net income/share CAGR 1.25-1.5x OGI.TO's 73.98%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
5683.87%
10Y equity/share CAGR above 1.5x OGI.TO's 415.67%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-29.32%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-23.00%
Negative 3Y equity/share growth while OGI.TO is at 170.59%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.38%
AR growth well above OGI.TO's 2.35%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.89%
Inventory growth well above OGI.TO's 2.50%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.63%
Negative asset growth while OGI.TO invests at 10.96%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.64%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-5.92%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-29.11%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
7.54%
SG&A declining or stable vs. OGI.TO's 20.28%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.